Disease on EC 2.4.1.18 - 1,4-alpha-glucan branching enzyme
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
1,4-alpha-glucan branching enzyme deficiency
A new variant of type IV glycogenosis with primary cardiac manifestation and complete branching enzyme deficiency. In vivo detection by heart muscle biopsy.
1,4-alpha-glucan branching enzyme deficiency
A new variant of type IV glycogenosis: deficiency of branching enzyme activity without apparent progressive liver disease.
1,4-alpha-glucan branching enzyme deficiency
A novel mouse model that recapitulates adult-onset glycogenosis type 4.
1,4-alpha-glucan branching enzyme deficiency
Acute but transient neurological deterioration revealing adult polyglucosan body disease.
1,4-alpha-glucan branching enzyme deficiency
Adult polyglucosan body disease: a rare presentation with chronic liver disease and ground-glass hepatocellular inclusions.
1,4-alpha-glucan branching enzyme deficiency
Allele frequency and likely impact of the glycogen branching enzyme deficiency gene in Quarter Horse and Paint Horse populations.
1,4-alpha-glucan branching enzyme deficiency
Alteration of mitochondrial function in the livers of mice with glycogen branching enzyme deficiency.
1,4-alpha-glucan branching enzyme deficiency
Amylopectinosis disease isolated to the heart with normal glycogen branching enzyme activity and gene sequence.
1,4-alpha-glucan branching enzyme deficiency
Apparent absence of glycogen branching enzyme activity in phosphofructokinase deficiency.
1,4-alpha-glucan branching enzyme deficiency
Branching enzyme activity of cultured amniocytes and chorionic villi: prenatal testing for type IV glycogen storage disease.
1,4-alpha-glucan branching enzyme deficiency
Branching enzyme deficiency/glycogenosis storage disease type IV presenting as a severe congenital hypotonia: Muscle biopsy and autopsy findings, biochemical and molecular genetic studies.
1,4-alpha-glucan branching enzyme deficiency
Branching enzyme deficiency: expanding the clinical spectrum.
1,4-alpha-glucan branching enzyme deficiency
Characterization of the endosperm starch and the pleiotropic effects of biosynthetic enzymes on their properties in novel mutant rice lines with high resistant starch and amylose content.
1,4-alpha-glucan branching enzyme deficiency
Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV).
1,4-alpha-glucan branching enzyme deficiency
Congenital type IV glycogenosis: the spectrum of pleomorphic polyglucosan bodies in muscle, nerve, and spinal cord with two novel mutations in the GBE1 gene.
1,4-alpha-glucan branching enzyme deficiency
Deficiencies in both starch synthase IIIa and branching enzyme IIb lead to a significant increase in amylose in SSIIa-inactive japonica rice seeds.
1,4-alpha-glucan branching enzyme deficiency
Efficient correction of a deleterious point mutation in primary horse fibroblasts with CRISPR-Cas9.
1,4-alpha-glucan branching enzyme deficiency
Equine diseases caused by known genetic mutations.
1,4-alpha-glucan branching enzyme deficiency
Evaluation of allele frequencies of inherited disease genes in subgroups of American Quarter Horses.
1,4-alpha-glucan branching enzyme deficiency
Generation of a novel mouse model that recapitulates early and adult onset glycogenosis type IV.
1,4-alpha-glucan branching enzyme deficiency
Glycogen branching enzyme deficiency in adult polyglucosan body disease.
1,4-alpha-glucan branching enzyme deficiency
Glycogen branching enzyme deficiency in an infant with severe congenital hypotonia: an emerging diagnosis of muscle weakness in the perinatal period.
1,4-alpha-glucan branching enzyme deficiency
Glycogen branching enzyme deficiency in quarter horse foals.
1,4-alpha-glucan branching enzyme deficiency
Glycogen storage disease type IV: inherited deficiency of branching enzyme activity in cats.
1,4-alpha-glucan branching enzyme deficiency
Hallmarks of oxidative stress in the livers of aged mice with mild glycogen branching enzyme deficiency.
1,4-alpha-glucan branching enzyme deficiency
Isolation of human glycogen branching enzyme cDNAs by screening complementation in yeast.
1,4-alpha-glucan branching enzyme deficiency
Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis).
1,4-alpha-glucan branching enzyme deficiency
Maize starch-branching enzyme isoforms and amylopectin structure. In the absence of starch-branching enzyme IIb, the further absence of starch-branching enzyme Ia leads to increased branching.
1,4-alpha-glucan branching enzyme deficiency
Multisystem involvement in a patient due to accumulation of amylopectin-like material with diminished branching enzyme activity.
1,4-alpha-glucan branching enzyme deficiency
Neuromuscular forms of glycogen branching enzyme deficiency.
1,4-alpha-glucan branching enzyme deficiency
Null mutations and lethal congenital form of glycogen storage disease type IV.
1,4-alpha-glucan branching enzyme deficiency
Polyglucosan neurotoxicity caused by glycogen branching enzyme deficiency can be reversed by inhibition of glycogen synthase.
1,4-alpha-glucan branching enzyme deficiency
Proteomic characterisation of polyglucosan bodies in skeletal muscle in RBCK1 deficiency.
1,4-alpha-glucan branching enzyme deficiency
Severe cardiopathy in branching enzyme deficiency.
1,4-alpha-glucan branching enzyme deficiency
SGK1 (glucose transport), dishevelled2 (wnt signaling), LC3/p62 (autophagy) and p53 (apoptosis) proteins are unaltered in Lafora disease.
1,4-alpha-glucan branching enzyme deficiency
Structural basis of glycogen branching enzyme deficiency and pharmacologic rescue by rational peptide design.
1,4-alpha-glucan branching enzyme deficiency
The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies.
1,4-alpha-glucan branching enzyme deficiency
Type IV glycogen storage disease: branching enzyme deficiency in skin fibroblasts and possible heterozygote detection.
1,4-alpha-glucan branching enzyme deficiency
[Adult polyglucosan antibody disease. Case report with predominant involvement of the central and peripheral nervous system and branching enzyme defect in leukocytes]
1,4-alpha-glucan branching enzyme deficiency
[Glycogen branching enzyme deficiency (Andersen disease)]
1,4-alpha-glucan branching enzyme deficiency
[Polysaccharide amylopectin-type storage myopathy]
1,4-alpha-glucan branching enzyme deficiency
[Severe cardiomyopathy revealing amylopectinosis. Two cases in adolescents from the same family]
6-phosphofructokinase deficiency
Apparent absence of glycogen branching enzyme activity in phosphofructokinase deficiency.
Acute Kidney Injury
Ginaton injection alleviates cisplatin-induced renal interstitial fibrosis in rats via inhibition of apoptosis through regulation of the p38MAPK/TGF-?1 and p38MAPK/HIF-1? pathways.
Adenocarcinoma of Lung
Hypoxia-induced GBE1 expression promotes tumor progression through metabolic reprogramming in lung adenocarcinoma.
Adenoma
Essential role of constitutive androstane receptor in Ginkgo biloba extract induced liver hypertrophy and hepatocarcinogenesis.
Albuminuria
Nrf-2 mediated heme oxygenase-1 activation contributes to the anti-inflammatory and renal protective effects of Ginkgo biloba extract in diabetic nephropathy.
Alzheimer Disease
An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia.
Alzheimer Disease
Mixing Ginkgo biloba Extract with Sesame Extract and Turmeric Oil Increases Bioavailability of Ginkgolide A in Mice Brain.
Amnesia
Effects of ginkgo biloba extract on impairment of learning induced by cerebral ischemia in mice.
amp deaminase deficiency
[Diagnostic significance of muscle biopsies in metabolic myopathies. II. Clinical biochemistry]
Anaphylaxis
Antiallergic and Antiarthritic Effects of Stem Bark Extract of Glyphaea brevis (Spreng) Monachino (Tiliaceae) in Murine Models.
Anaphylaxis
Histochemical investigations on phosphorylase, branching enzyme and glycogen in guinea pig livers in experimental anaphylactic and histaminic shock.
Angina Pectoris
An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia.
Aortic Rupture
Ginkgo biloba extracts prevent aortic rupture in angiotensin II-infused hypercholesterolemic mice.
Arrhythmias, Cardiac
Effect of Ginkgo biloba extract on pacemaker channels encoded by HCN gene.
Arrhythmias, Cardiac
[Protection effect of Yindan Xinnaotong capsule and main compositions compatibility on myocardial ischemia/reperfusion injury].
Arthritis
Antiallergic and Antiarthritic Effects of Stem Bark Extract of Glyphaea brevis (Spreng) Monachino (Tiliaceae) in Murine Models.
Asthma
Herb-drug interactions: Effect of Ginkgo biloba extract on the pharmacokinetics of theophylline in rats.
Asthma
The effect of Ginkgo Biloba extract on the expression of PKCalpha in the inflammatory cells and the level of IL-5 in induced sputum of asthmatic patients.
Ataxia
Role of inhibiting Chk1-p53 pathway in hepatotoxicity caused by chronic arsenic exposure from coal-burning.
Atherosclerosis
Ginkgo biloba extract inhibits tumor necrosis factor-alpha-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells.
Atherosclerosis
Ginkgo biloba extract reduces high-glucose-induced endothelial reactive oxygen species generation and cell adhesion molecule expression by enhancing HO-1 expression via Akt/eNOS and p38 MAP kinase pathways.
Atherosclerosis
Ginkgo biloba inhibits hydrogen peroxide-induced activation of nuclear factor kappa B in vascular endothelial cells.
Atherosclerosis
Ginkgo Biloba Leaf Extract Attenuates Atherosclerosis in Streptozotocin-Induced Diabetic ApoE-/- Mice by Inhibiting Endoplasmic Reticulum Stress via Restoration of Autophagy through the mTOR Signaling Pathway.
Atherosclerosis
Ginkgo bilobaExtract(GbE) Enhances the Anti-atherogenic Effect of Cilostazol by InhibitingROS Generation.
Blister
Elective surgery for giant bullous emphysema: a 5-year clinical and functional follow-up.
Bradycardia
Long-term feeding of Ginkgo biloba extract impairs peripheral circulation and hepatic function in aged spontaneously hypertensive rats.
Brain Edema
Ginkgo biloba extract facilitates recovery from penetrating brain injury in adult male rats.
Brain Injuries
Effects of gingko biloba extract on glutamate-induced [Ca2+]i changes in cultured cortical astrocytes after hypoxia/reoxygenation, H2O2 or L-glutamate injury.
Brain Injuries
Ginkgolide B promotes neuronal differentiation through the Wnt/?-catenin pathway in neural stem cells of the postnatal mammalian subventricular zone.
Brain Ischemia
Effect of Ginkgo biloba leaf extract on electroencephalography of rat with cerebral ischemia and reperfusion.
Brain Ischemia
Effects of Ginkgo biloba extract on acute cerebral ischemia in rats analyzed by magnetic resonance spectroscopy.
Brain Ischemia
[Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof]
Breast Neoplasms
Chemopreventive effects of Ginkgo biloba extract in estrogen-negative human breast cancer cells.
Carcinogenesis
Hepatocellular Carcinomas in B6C3F1 Mice Treated with Ginkgo biloba Extract for Two Years Differ from Spontaneous Liver Tumors in Cancer Gene Mutations and Genomic Pathways.
Carcinogenesis
Unique microRNA alterations in hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice.
Carcinoma
Histochemical studies of glycogen metabolizing enzymes in normal and abnormal human cervical epithelium.
Carcinoma
[Experimental studies of the protective effect of ginkgo biloba extract (GBE) on cisplatin-induced toxicity in rats]
Carcinoma in Situ
Histochemical studies of glycogen metabolizing enzymes in normal and abnormal human cervical epithelium.
Carcinoma, Hepatocellular
Hepatocellular Carcinomas in B6C3F1 Mice Treated with Ginkgo biloba Extract for Two Years Differ from Spontaneous Liver Tumors in Cancer Gene Mutations and Genomic Pathways.
Carcinoma, Hepatocellular
Isolation of human glycogen branching enzyme cDNAs by screening complementation in yeast.
Carcinoma, Hepatocellular
Unique microRNA alterations in hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice.
Carcinoma, Squamous Cell
[Experimental studies of the protective effect of ginkgo biloba extract (GBE) on cisplatin-induced toxicity in rats]
Cardiomegaly
Cardioprotective Action of Ginkgo biloba Extract against Sustained ?-Adrenergic Stimulation Occurs via Activation of M2/NO Pathway.
Cardiomyopathies
Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis).
Cardiomyopathy, Dilated
Neonatal hypotonia and cardiomyopathy secondary to type IV glycogenosis.
Cardiovascular Diseases
Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular diseases.
Cardiovascular Diseases
Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications.
Catalepsy
Antiallergic and Antiarthritic Effects of Stem Bark Extract of Glyphaea brevis (Spreng) Monachino (Tiliaceae) in Murine Models.
Cataract
Antidiabetic cataract effects of GbE, rutin and quercetin are mediated by the inhibition of oxidative stress and polyol pathway.
Cataract
Ginkgo biloba extract prevents against apoptosis induced by high glucose in human lens epithelial cells.
Cerebral Infarction
Ginkgo biloba extract protects diabetic rats against cerebral ischemia?reperfusion injury by suppressing oxidative stress and upregulating the expression of glutamate transporter 1.
Cerebral Infarction
Injections of ginkgo in the treatment of cerebral infarction: a systematic review and network Meta-analysis.
Cerebral Infarction
Mechanisms Associated with Protective Effects of Ginkgo Biloba Leaf Extracton in Rat Cerebral Ischemia Reperfusion Injury.
Cerebral Infarction
[Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof]
Cholelithiasis
Identification and replication of six new loci associated with gallstone disease.
Colitis, Ischemic
Therapeutic effects of Ginkgo biloba extract against acute ischemic colitis.
Colonic Neoplasms
Antioxidant and antigenotoxic activities of Ginkgo biloba L. leaf extract are retained after in vitro gastrointestinal digestive conditions.
Colorectal Neoplasms
Phase II study of combined 5-fluorouracil/ Ginkgo biloba extract (GBE 761 ONC) therapy in 5-fluorouracil pretreated patients with advanced colorectal cancer.
Congenital Abnormalities
Effects of Ginkgo biloba extract on the embryo-fetal development in Wistar rats.
Coronary Artery Disease
Ginkgo biloba extract improves coronary blood flow in patients with coronary artery disease: role of endothelium-dependent vasodilation.
Coronary Disease
[Change of peripheral blood monocytes derived macrophage scavenger receptors activity in patients with coronary heart disease, and the intervention effect of ginkgo biloba extract]
Craniocerebral Trauma
[Myocardial damage and change of mitochondrial Mn-superoxide dismutase activity in craniocerebral injured rats and the interventing effect of ginkgo biloba extract]
Dehydration
Biosynthesis, structure and functionality of starch granules in maize inbred lines with different kernel dehydration rate.
Dementia
A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline.
Dementia
A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.
Dementia
Effectiveness of standardized ginkgo biloba extract on cognitive symptoms of dementia with a six-month treatment: a bivariate random effect meta-analysis.
Dementia
Mixing Ginkgo biloba Extract with Sesame Extract and Turmeric Oil Increases Bioavailability of Ginkgolide A in Mice Brain.
Diabetes Mellitus
Ethanolic Ginkgo biloba leaf extract prevents renal fibrosis through Akt/mTOR signaling in diabetic nephropathy.
Diabetes Mellitus
New Insight into the Mechanisms of Ginkgo Biloba Extract in Vascular Aging Prevention.
Diabetes Mellitus
The effects of Ginkgo biloba extract (GBe) on axonal transport microvasculature and morphology of sciatic nerve in streptozotocin-induced diabetic rats.
Diabetes Mellitus, Type 2
Mechanism-Based Modeling of Gastric Emptying Rate and Gallbladder Emptying in Response to Caloric Intake.
Diabetic Angiopathies
Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications.
Diabetic Nephropathies
Ethanolic Ginkgo biloba leaf extract prevents renal fibrosis through Akt/mTOR signaling in diabetic nephropathy.
Diabetic Nephropathies
Protective effects of serum containing Ginkgo biloba extract on glomerulosclerosis in rat mesangial cells.
Dyslipidemias
Beneficial effects of Ginkgo biloba extract on insulin signaling cascade, dyslipidemia, and body adiposity of diet-induced obese rats.
Erythema
[Changes of nitric oxide after trichloroethylene irritation in hairless mice skin and protection of ginkgo biloba extract and vitamin E]
Gastrointestinal Hemorrhage
Therapeutic effects of Ginkgo biloba extract against acute ischemic colitis.
Genetic Diseases, Inborn
Non-lethal congenital hypotonia due to glycogen storage disease type IV.
Genetic Diseases, Inborn
[Severe cardiomyopathy revealing amylopectinosis. Two cases in adolescents from the same family]
Glaucoma
Ginkgo biloba Extract and Bilberry Anthocyanins Improve Visual Function in Patients with Normal Tension Glaucoma.
Glycogen Storage Disease
A case of congenital glycogen storage disease type IV with a novel GBE1 mutation.
Glycogen Storage Disease
A Case of Glycogen Storage Disease IV with Rare Homozygous Mutations in the Glycogen Branching Enzyme Gene.
Glycogen Storage Disease
A complex rearrangement in GBE1 causes both perinatal hypoglycemic collapse and late-juvenile-onset neuromuscular degeneration in glycogen storage disease type IV of Norwegian forest cats.
Glycogen Storage Disease
A GYS1 gene mutation is highly associated with polysaccharide storage myopathy in Cob Normand draught horses.
Glycogen Storage Disease
A Modified Enzymatic Method for Measurement of Glycogen Content in Glycogen Storage Disease Type IV.
Glycogen Storage Disease
A new variant of type IV glycogenosis with primary cardiac manifestation and complete branching enzyme deficiency. In vivo detection by heart muscle biopsy.
Glycogen Storage Disease
A new variant of type IV glycogenosis: deficiency of branching enzyme activity without apparent progressive liver disease.
Glycogen Storage Disease
A novel missense mutation in the glycogen branching enzyme gene in a child with myopathy and hepatopathy.
Glycogen Storage Disease
Alteration of mitochondrial function in the livers of mice with glycogen branching enzyme deficiency.
Glycogen Storage Disease
Association of the Congenital Neuromuscular Form of Glycogen Storage Disease Type IV With a Large Deletion and Recurrent Frameshift Mutation.
Glycogen Storage Disease
Branching enzyme activity of cultured amniocytes and chorionic villi: prenatal testing for type IV glycogen storage disease.
Glycogen Storage Disease
Branching enzyme in erythrocytes. Detection of type IV glycogenosis homozygotes and heterozygotes.
Glycogen Storage Disease
Cardiac Involvement in Glycogen Storage Disease Type IV: Two Cases and the Two Ends of a Spectrum.
Glycogen Storage Disease
Case of Neonatal Fatality from Neuromuscular Variant of Glycogen Storage Disease Type IV.
Glycogen Storage Disease
Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV).
Glycogen Storage Disease
Concomitant branching enzyme and phosphorylase deficiencies. An unusual glycogenosis with extensive neuronal polyglucosan storage.
Glycogen Storage Disease
Fatal infantile neuromuscular presentation of glycogen storage disease type IV.
Glycogen Storage Disease
Generation of a novel mouse model that recapitulates early and adult onset glycogenosis type IV.
Glycogen Storage Disease
Genetic mapping of GBE1 and its association with glycogen storage disease IV in American Quarter horses.
Glycogen Storage Disease
Glycogen branching enzyme (GBE1) mutation causing equine glycogen storage disease IV.
Glycogen Storage Disease
Glycogen storage disease type IV: inherited deficiency of branching enzyme activity in cats.
Glycogen Storage Disease
Glycogen storage disease type IV: novel mutations and molecular characterization of a heterogeneous disorder.
Glycogen Storage Disease
Immunohistochemical and ultrastructural changes in the brain in probable adult glycogenosis type IV: adult polyglucosan body disease.
Glycogen Storage Disease
Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis).
Glycogen Storage Disease
Living Donor Liver Transplantation in a Korean Child with Glycogen Storage Disease Type IV and a GBE1 Mutation.
Glycogen Storage Disease
Neonatal type IV glycogen storage disease associated with "null" mutations in glycogen branching enzyme 1.
Glycogen Storage Disease
Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of glycogen storage disease type IV associated with a new mutation in GBE1 gene.
Glycogen Storage Disease
Non-lethal congenital hypotonia due to glycogen storage disease type IV.
Glycogen Storage Disease
Novel missense mutations in the glycogen-branching enzyme gene in adult polyglucosan body disease.
Glycogen Storage Disease
Polyglucosan neurotoxicity caused by glycogen branching enzyme deficiency can be reversed by inhibition of glycogen synthase.
Glycogen Storage Disease
Prenatal diagnosis of glycogen storage disease type IV using PCR-based DNA mutation analysis.
Glycogen Storage Disease
Severe neonatal onset of glycogenosis type IV: clinical and laboratory findings leading to diagnosis in two siblings.
Glycogen Storage Disease
Studies of glycogen branching enzyme. Preparation and properties of -1,4-glucan- -1,4-glucan 6-glycosyltransferase and its action on the characteristic polysaccharide of the liver of children with Type IV glycogen storage disease.
Glycogen Storage Disease
Studies of the residual glycogen branching enzyme activity present in human skin fibroblasts from patients with type IV glycogen storage disease.
Glycogen Storage Disease
Systemic Correction of Murine Glycogen Storage Disease Type IV by an AAV-Mediated Gene Therapy.
Glycogen Storage Disease
The adult polyglucosan body disease mutation GBE1 c.1076A>C occurs at high frequency in persons of Ashkenazi Jewish background.
Glycogen Storage Disease
The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies.
Glycogen Storage Disease
Type IV glycogen storage disease: branching enzyme deficiency in skin fibroblasts and possible heterozygote detection.
Glycogen Storage Disease
Type IV glycogenosis. Patient with absence of a branching enzyme alpha-1,4-glucan:alpha-1,4-glucan 6-glycosyl transferase.
Glycogen Storage Disease
[A study of the abnormal polysaccharide in a child with type IV glycogen storage disease (author's transl)]
Glycogen Storage Disease
[Congenital variant of type IV glycogenosis. Anatomoclinical report of a case]
Glycogen Storage Disease
[Severe cardiomyopathy revealing amylopectinosis. Two cases in adolescents from the same family]
Glycogen Storage Disease Type IV
A case of congenital glycogen storage disease type IV with a novel GBE1 mutation.
Glycogen Storage Disease Type IV
A complex rearrangement in GBE1 causes both perinatal hypoglycemic collapse and late-juvenile-onset neuromuscular degeneration in glycogen storage disease type IV of Norwegian forest cats.
Glycogen Storage Disease Type IV
A GYS1 gene mutation is highly associated with polysaccharide storage myopathy in Cob Normand draught horses.
Glycogen Storage Disease Type IV
A Modified Enzymatic Method for Measurement of Glycogen Content in Glycogen Storage Disease Type IV.
Glycogen Storage Disease Type IV
A new variant of type IV glycogenosis with primary cardiac manifestation and complete branching enzyme deficiency. In vivo detection by heart muscle biopsy.
Glycogen Storage Disease Type IV
A new variant of type IV glycogenosis: deficiency of branching enzyme activity without apparent progressive liver disease.
Glycogen Storage Disease Type IV
Adult polyglucosan body disease: a rare presentation with chronic liver disease and ground-glass hepatocellular inclusions.
Glycogen Storage Disease Type IV
Allele frequency and likely impact of the glycogen branching enzyme deficiency gene in Quarter Horse and Paint Horse populations.
Glycogen Storage Disease Type IV
Alteration of mitochondrial function in the livers of mice with glycogen branching enzyme deficiency.
Glycogen Storage Disease Type IV
Amylopectinosis disease isolated to the heart with normal glycogen branching enzyme activity and gene sequence.
Glycogen Storage Disease Type IV
Association of the Congenital Neuromuscular Form of Glycogen Storage Disease Type IV With a Large Deletion and Recurrent Frameshift Mutation.
Glycogen Storage Disease Type IV
Branching enzyme deficiency: expanding the clinical spectrum.
Glycogen Storage Disease Type IV
Branching enzyme in erythrocytes. Detection of type IV glycogenosis homozygotes and heterozygotes.
Glycogen Storage Disease Type IV
Cardiac Involvement in Glycogen Storage Disease Type IV: Two Cases and the Two Ends of a Spectrum.
Glycogen Storage Disease Type IV
Case of Neonatal Fatality from Neuromuscular Variant of Glycogen Storage Disease Type IV.
Glycogen Storage Disease Type IV
Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV).
Glycogen Storage Disease Type IV
Congenital type IV glycogenosis: the spectrum of pleomorphic polyglucosan bodies in muscle, nerve, and spinal cord with two novel mutations in the GBE1 gene.
Glycogen Storage Disease Type IV
Efficient correction of a deleterious point mutation in primary horse fibroblasts with CRISPR-Cas9.
Glycogen Storage Disease Type IV
Evaluation of allele frequencies of inherited disease genes in subgroups of American Quarter Horses.
Glycogen Storage Disease Type IV
Fatal infantile neuromuscular presentation of glycogen storage disease type IV.
Glycogen Storage Disease Type IV
Generation of a novel mouse model that recapitulates early and adult onset glycogenosis type IV.
Glycogen Storage Disease Type IV
Genetic mapping of GBE1 and its association with glycogen storage disease IV in American Quarter horses.
Glycogen Storage Disease Type IV
Glycogen branching enzyme deficiency in adult polyglucosan body disease.
Glycogen Storage Disease Type IV
Glycogen branching enzyme deficiency in an infant with severe congenital hypotonia: an emerging diagnosis of muscle weakness in the perinatal period.
Glycogen Storage Disease Type IV
Glycogen branching enzyme deficiency in quarter horse foals.
Glycogen Storage Disease Type IV
Glycogen storage disease type IV: inherited deficiency of branching enzyme activity in cats.
Glycogen Storage Disease Type IV
Glycogen storage disease type IV: novel mutations and molecular characterization of a heterogeneous disorder.
Glycogen Storage Disease Type IV
Hallmarks of oxidative stress in the livers of aged mice with mild glycogen branching enzyme deficiency.
Glycogen Storage Disease Type IV
Isolation of human glycogen branching enzyme cDNAs by screening complementation in yeast.
Glycogen Storage Disease Type IV
Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis).
Glycogen Storage Disease Type IV
Living Donor Liver Transplantation in a Korean Child with Glycogen Storage Disease Type IV and a GBE1 Mutation.
Glycogen Storage Disease Type IV
Neuromuscular forms of glycogen branching enzyme deficiency.
Glycogen Storage Disease Type IV
Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of glycogen storage disease type IV associated with a new mutation in GBE1 gene.
Glycogen Storage Disease Type IV
Non-lethal congenital hypotonia due to glycogen storage disease type IV.
Glycogen Storage Disease Type IV
Novel missense mutations in the glycogen-branching enzyme gene in adult polyglucosan body disease.
Glycogen Storage Disease Type IV
Null mutations and lethal congenital form of glycogen storage disease type IV.
Glycogen Storage Disease Type IV
Placental Involvement in Glycogen Storage Disease Type IV.
Glycogen Storage Disease Type IV
Polyglucosan neurotoxicity caused by glycogen branching enzyme deficiency can be reversed by inhibition of glycogen synthase.
Glycogen Storage Disease Type IV
Prenatal diagnosis of glycogen storage disease type IV using PCR-based DNA mutation analysis.
Glycogen Storage Disease Type IV
Structural basis of glycogen branching enzyme deficiency and pharmacologic rescue by rational peptide design.
Glycogen Storage Disease Type IV
Systemic Correction of Murine Glycogen Storage Disease Type IV by an AAV-Mediated Gene Therapy.
Glycogen Storage Disease Type IV
The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies.
Glycogen Storage Disease Type IV
Type IV glycogenosis. Patient with absence of a branching enzyme alpha-1,4-glucan:alpha-1,4-glucan 6-glycosyl transferase.
Glycogen Storage Disease Type IV
[Congenital variant of type IV glycogenosis. Anatomoclinical report of a case]
Glycogen Storage Disease Type IV
[Severe cardiomyopathy revealing amylopectinosis. Two cases in adolescents from the same family]
Glycogen Storage Disease Type VII
Apparent absence of glycogen branching enzyme activity in phosphofructokinase deficiency.
glycogenin glucosyltransferase deficiency
Proteomic characterisation of polyglucosan bodies in skeletal muscle in RBCK1 deficiency.
Hearing Loss
A combination of cilostazol and Ginkgo biloba extract protects against cisplatin-induced Cochleo-vestibular dysfunction by inhibiting the mitochondrial apoptotic and ERK pathways.
Hearing Loss
Ginkgo Biloba Extract Attenuates Oxidative Stress and Apoptosis in Mouse Cochlear Neural Stem Cells.
Hearing Loss
Ginkgo Biloba Extract Enhances Differentiation and Performance of Neural Stem Cells in Mouse Cochlea.
Heart Failure
Ginkgo biloba Extract Reduces Hippocampus Inflammatory Responses, Improves Cardiac Functions And Depressive Behaviors In A Heart Failure Mouse Model.
Heart Failure
Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis).
Hydrocephalus
[Effect of Ginkgo biloba extract on neuronal apoptosis in rabbit with kaolin-induced syringomyelia]
Hyperalgesia
Ginkgo biloba extract attenuates hyperalgesia in a rat model of vincristine-induced peripheral neuropathy.
Hyperglycemia
Beneficial effects of Ginkgo biloba extract on insulin signaling cascade, dyslipidemia, and body adiposity of diet-induced obese rats.
Hyperglycemia
Nrf-2 mediated heme oxygenase-1 activation contributes to the anti-inflammatory and renal protective effects of Ginkgo biloba extract in diabetic nephropathy.
Hypertension
Ginkgo biloba extract attenuates the development of hypertension in deoxycorticosterone acetate-salt hypertensive rats.
Hypertension
Long-term feeding of Ginkgo biloba extract impairs peripheral circulation and hepatic function in aged spontaneously hypertensive rats.
Immune System Diseases
Ginkgo biloba extract suppresses endotoxin-mediated monocyte activation by inhibiting nitric oxide- and tristetraprolin-mediated toll-like receptor 4 expression.
Infant, Newborn, Diseases
Genetic mapping of GBE1 and its association with glycogen storage disease IV in American Quarter horses.
Infarction, Middle Cerebral Artery
[Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof]
Infections
Cholesterol-rich lipid rafts both in cellular and viral membrane are critical for caprine parainfluenza virus type3 entry and infection in host cells.
Insulin Resistance
Ginkgo biloba extract enhances glucose tolerance in hyperinsulinism-induced hepatic cells.
Ischemic Stroke
A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline.
Ischemic Stroke
Ginkgo biloba extract and its diterpene ginkgolide constituents ameliorate the metabolic disturbances caused by recombinant tissue plasminogen activator in rat prefrontal cortex.
Ischemic Stroke
Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
Ischemic Stroke
Ginkgol Biloba extract as an adjunctive treatment for ischemic stroke: A systematic review and meta-analysis of randomized clinical trials.
Lafora Disease
Proteomic characterisation of polyglucosan bodies in skeletal muscle in RBCK1 deficiency.
Liver Cirrhosis
Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-?B/I?B?, and Bcl-2/Bax signaling.
Liver Cirrhosis
Hepatoprotective effect of ultrasonicated ginseng berry extract on a rat mild bile duct ligation model.
Liver Diseases
A Case of Glycogen Storage Disease IV with Rare Homozygous Mutations in the Glycogen Branching Enzyme Gene.
Liver Diseases
A new variant of type IV glycogenosis: deficiency of branching enzyme activity without apparent progressive liver disease.
Liver Diseases, Alcoholic
The Edible Insect Gryllus bimaculatus Protects against Gut-Derived Inflammatory Responses and Liver Damage in Mice after Acute Alcohol Exposure.
Liver Failure
A new variant of type IV glycogenosis: deficiency of branching enzyme activity without apparent progressive liver disease.
Low Tension Glaucoma
Ginkgo biloba Extract and Bilberry Anthocyanins Improve Visual Function in Patients with Normal Tension Glaucoma.
Lymphangioma, Cystic
Fetal type IV glycogen storage disease: clinical, enzymatic, and genetic data of a pure muscular form with variable and early antenatal manifestations in the same family.
Lymphoma
Safety evaluation of highly-branched cyclic dextrin and a 1,4-alpha-glucan branching enzyme from Bacillus stearothermophilus.
Memory Disorders
Ginkgo biloba extract improves spatial memory in rats mainly but not exclusively via a histaminergic mechanism.
Memory Disorders
Protective effect of Ginkgo biloba leaf extract on learning and memory deficit induced by aluminum in model rats.
Metabolic Diseases
Apparent absence of glycogen branching enzyme activity in phosphofructokinase deficiency.
Metabolic Diseases
Ginkgo biloba extract improves insulin signaling and attenuates inflammation in retroperitoneal adipose tissue depot of obese rats.
Multiple Sclerosis
Hypomorphic MGAT5 polymorphisms promote multiple sclerosis cooperatively with MGAT1 and interleukin-2 and 7 receptor variants.
Muscle Hypotonia
Branching enzyme deficiency/glycogenosis storage disease type IV presenting as a severe congenital hypotonia: Muscle biopsy and autopsy findings, biochemical and molecular genetic studies.
Muscle Hypotonia
Glycogen branching enzyme deficiency in an infant with severe congenital hypotonia: an emerging diagnosis of muscle weakness in the perinatal period.
Muscle Weakness
Glycogen branching enzyme deficiency in an infant with severe congenital hypotonia: an emerging diagnosis of muscle weakness in the perinatal period.
Muscular Diseases
A novel missense mutation in the glycogen branching enzyme gene in a child with myopathy and hepatopathy.
Muscular Diseases
Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV).
Muscular Diseases
Evaluation of allele frequencies of inherited disease genes in subgroups of American Quarter Horses.
Muscular Diseases
Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis).
Muscular Diseases
Proteomic characterisation of polyglucosan bodies in skeletal muscle in RBCK1 deficiency.
Neoplasms
Effects of Ginkgo biloba on chemically-induced mammary tumors in rats receiving tamoxifen.
Neoplasms
Enhancement of radiation effect by Ginkgo biloba extract in C3H mouse fibrosarcoma.
Neoplasms
Gingko biloba extract reduces VEGF and CXCL-8/IL-8 levels in keratinocytes with cumulative effect with epigallocatechin-3-gallate.
Neoplasms
Ginkgo biloba extract inhibits tumor necrosis factor-alpha-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells.
Neoplasms
Ginkgo biloba extract suppresses endotoxin-mediated monocyte activation by inhibiting nitric oxide- and tristetraprolin-mediated toll-like receptor 4 expression.
Neoplasms
Hepatocellular Carcinomas in B6C3F1 Mice Treated with Ginkgo biloba Extract for Two Years Differ from Spontaneous Liver Tumors in Cancer Gene Mutations and Genomic Pathways.
Neoplasms
Pathological glycogenesis through glycogen synthase 1 and suppression of excessive AMP kinase activity in myeloid leukemia cells.
Neoplasms
The effects of Ginkgo biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo.
Neoplasms
The histochemically demonstrable phosphorylase and branching enzyme activity in some animals' ascites tumour cells.
Neuroblastoma
Ginkgo biloba extract increases neurite outgrowth and activates the Akt/mTOR pathway.
Neuroblastoma
Ginkgo biloba extract protects human neuroblastoma SH-SY5Y cells against oxidative glutamate toxicity by activating redoxosome-p66Shc.
Neurodegenerative Diseases
Ginkgo biloba extract protects human neuroblastoma SH-SY5Y cells against oxidative glutamate toxicity by activating redoxosome-p66Shc.
Neurodegenerative Diseases
Ginkgolide B promotes neuronal differentiation through the Wnt/?-catenin pathway in neural stem cells of the postnatal mammalian subventricular zone.
Neuroinflammatory Diseases
Ginkgo biloba L. extract protects against chronic cerebral hypoperfusion by modulating neuroinflammation and the cholinergic system.
Obesity
Beneficial effects of Ginkgo biloba extract on insulin signaling cascade, dyslipidemia, and body adiposity of diet-induced obese rats.
Obesity
Ginkgo biloba extract (GbE) attenuates obesity and anxious/depressive-like behaviours induced by ovariectomy.
Obesity
Ginkgo biloba Extract (GbE) Stimulates the Hypothalamic Serotonergic System and Attenuates Obesity in Ovariectomized Rats.
Obesity
Ginkgo biloba extract enhances glucose tolerance in hyperinsulinism-induced hepatic cells.
Osteoporosis
Effects of ginkgo biloba on in vitro osteoblast cells and ovariectomized rat osteoclast cells.
Osteoporosis, Postmenopausal
Effects of ginkgo biloba on in vitro osteoblast cells and ovariectomized rat osteoclast cells.
Ototoxicity
[Experimental studies of the protective effect of ginkgo biloba extract (GBE) on cisplatin-induced toxicity in rats]
Pancreatic Neoplasms
Phase II study with 5-fluorouracil and ginkgo biloba extract (GBE 761 ONC) in patients with pancreatic cancer.
Paralysis
Evaluation of allele frequencies of inherited disease genes in subgroups of American Quarter Horses.
Paraplegia
Adult polyglucosan body disease in a patient originally diagnosed with Fabry's disease.
Peripheral Nervous System Diseases
Adult polyglucosan body disease in a patient originally diagnosed with Fabry's disease.
Peripheral Vascular Diseases
Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications.
Porphyrias
Glycogen branching enzyme controls cellular iron homeostasis via Iron Regulatory Protein 1 and mitoNEET.
Prostatic Neoplasms
An A/G polymorphism of core 2 branching enzyme gene is associated with prostate cancer.
Pterygium
Whole exome sequencing in foetal akinesia expands the genotype-phenotype spectrum of GBE1 glycogen storage disease mutations.
Relative Energy Deficiency in Sport
Sclerostin/Receptor Related Protein 4 and Ginkgo Biloba Extract Alleviates ?-Glycerophosphate-Induced Vascular Smooth Muscle Cell Calcification By Inhibiting Wnt/?-Catenin Pathway.
Reperfusion Injury
Effects of Gingko biloba extract on gap junction changes induced by reperfusion/reoxygenation after ischemia/hypoxia in rat brain.
Reperfusion Injury
The Change of the Spinal Cord Ischemia-Reperfusion Injury in Mitochondrial Passway and the Effect of the Ginkgo biloba Extract's Preconditioning Intervention.
Reperfusion Injury
The protective effect of goji berry extract in ischemic reperfusion in testis torsion.
Retinal Diseases
Procyanidin B2 and rutin in Ginkgo biloba extracts protect human retinal pigment epithelial (RPE) cells from oxidative stress by modulating Nrf2 and Erk1/2 signalling.
Rhinitis, Allergic
[Effects of ginkgo biloba extract combined with glucocorticoid on olfactory function and inflammatory cytokines in mice with allergic rhinitis].
ring-type e3 ubiquitin transferase deficiency
Proteomic characterisation of polyglucosan bodies in skeletal muscle in RBCK1 deficiency.
Skin Diseases
Gingko biloba extract reduces VEGF and CXCL-8/IL-8 levels in keratinocytes with cumulative effect with epigallocatechin-3-gallate.
starch synthase (glycosyl-transferring) deficiency
SSIIIa-RNAi suppression associated changes in rice grain quality and starch biosynthesis metabolism in response to high temperature.
Starvation
Influence of in situ progressive N-terminal is still controversial truncation of glycogen branching enzyme in Escherichia coli DH5? on glycogen structure, accumulation, and bacterial viability.
Stomach Ulcer
Protective effects of Ginkgo biloba extract on the ethanol-induced gastric ulcer in rats.
Stroke
A preclinical randomized controlled study of ischemia treated with Ginkgo biloba extracts: Are complex components beneficial for treating acute stroke?
Stroke
A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline.
Stroke
Acute but transient neurological deterioration revealing adult polyglucosan body disease.
Stroke
Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
Stroke
Pressure segment length analysis of right ventricular function: influence of loading conditions.
Stroke
The Effects of Game-Based Breathing Exercise on Pulmonary Function in Stroke Patients: A Preliminary Study.
Thyroid Neoplasms
The Effect of Ginkgo biloba Extract on Genotoxic Damage in Patients with Differentiated Thyroid Carcinoma Receiving Thyroid Remnant Ablation with Iodine-131.
Tinnitus
An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia.
Tuberculosis
Characterization of the GH13 and GH57 glycogen branching enzymes from Petrotoga mobilis SJ95 and potential role in glycogen biosynthesis.
Tuberculosis
Crystal structure of full length mycobacterium tuberculosis H37Rv glycogen branching enzyme: Insights of N-terminal {beta}-sandwich in substrate specificity and enzymatic activity.
Tuberculosis
Discovery of Mycobacterium tuberculosis ?-1,4-glucan branching enzyme (GlgB) inhibitors by structure- and ligand-based virtual screening.
Tuberculosis
Expression and characterization of alpha-(1,4)-glucan branching enzyme Rv1326c of Mycobacterium tuberculosis H37Rv.
Tuberculosis
Redox biology of Mycobacterium tuberculosis H37Rv: protein-protein interaction between GlgB and WhiB1 involves exchange of thiol-disulfide.
Uveitis
The effects of Ginkgo biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo.
Vascular Diseases
Effects of ginkgo biloba extract on impairment of learning induced by cerebral ischemia in mice.
Vascular System Injuries
Activation of heme oxygenase-1 by Ginkgo biloba extract differentially modulates endothelial and smooth muscle-like progenitor cells for vascular repair.
Vertigo
An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia.
html completed